Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.56 | N/A |
| PEG Ratio (TTM) | 4.39 | N/A |
| P/S Ratio (TTM) | 6.83 | N/A |
| P/B Ratio (TTM) | 2.90 | N/A |
| P/FCF Ratio (TTM) | 5.09 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.21 | N/A |
| Price to 5YR AVG FCF Ratio | 18.47 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.10% | N/A |
| ROE (TTM) | 11.80% | N/A |
| Net Profit Margin (TTM) | 26.43% | N/A |
| ROIC 5YR AVG | 27.49% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.43% | 5.33% | 2.47% |
| Revenue | -6.28% | 24.42% | 15.22% |
| Net Income | 6.68% | 24.05% | 13.08% |
| Cash Flow | 175.55% | -40.25% | 145.72% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.63 | N/A |
| Quick Ratio (TTM) | 1.63 | N/A |
| D/E Ratio (TTM) | 1.18 | N/A |
| Interest Coverage (TTM) | -0.08 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.63 | N/A |
| LTL to 5YR AVG FCF | 6.87 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.99% | N/A |